Literature DB >> 15613609

Employment characteristics and job loss in patients awaiting surgery on the hip or knee.

K T Palmer1, P Milne, J Poole, C Cooper, D Coggon.   

Abstract

AIMS: To investigate the factors, including size of organisation, associated with job loss in patients awaiting surgery to the hip or knee joint.
METHODS: A questionnaire was mailed to 498 consecutive patients of working age listed at a district general hospital for major joint replacement, knee arthroscopy, or periacetabular osteotomy. Questions were asked about level of physical disability, duration of symptoms, employment circumstances at the time the joint problem began, and job changes since the onset of symptoms with their reasons. Analysis focused on those in work when their health problem began. Cox regression was used to examine risk factors for job loss related and unrelated to the joint problem, and results were summarised as adjusted hazard ratios (HRs) with 95% confidence intervals (95% CI).
RESULTS: Responses came from 370 (74%) of those mailed, including 278 who were in work when their joint problem began. Of these, 82 (30%) had left their original job mainly or partly because of their joint disorder. Such job loss was more common in those employed in small businesses (HR for <10 v > or =10 employees: 1.9, 95% CI 1.2-3.0) and those whose work involved standing for >2 hours per day (HR 2.7, 95% CI 1.2-6.1) No similar associations were found when jobs were left for other reasons. After adjustment for non-sedentary work the association with small business employment remained but was weaker (HR 1.5, 95% CI 0.9-2.5). Modifications to work and access to occupational health advice were not associated with better job retention.
CONCLUSIONS: In subjects with disabling hip or knee disease, job retention is poorer in those from small companies-a matter of concern given the rising prevalence of serious joint disease in the British workforce and the tendency of businesses to downsize and subcontract services to smaller enterprises.

Entities:  

Mesh:

Year:  2005        PMID: 15613609      PMCID: PMC1740858          DOI: 10.1136/oem.2004.014977

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  7 in total

1.  The effect of arthritis on working life expectancy.

Authors:  D Lacaille; R S Hogg
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

2.  Time trends in disability pensioning for rheumatoid arthritis, osteoarthritis and soft tissue rheumatism in Norway 1968-97.

Authors:  Hilde H Holte; Kristian Tambs; Tor Bjerkedal
Journal:  Scand J Public Health       Date:  2003       Impact factor: 3.021

3.  Estimation of prevalence rate ratios for cross sectional data: an example in occupational epidemiology.

Authors:  J Lee; K S Chia
Journal:  Br J Ind Med       Date:  1993-09

4.  The contribution of arthritis and arthritis disability to nonparticipation in the labor force: a Canadian example.

Authors:  E M Badley; P P Wang
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

5.  Health status in patients awaiting hip replacement for osteoarthritis.

Authors:  P Croft; M Lewis; C Wynn Jones; D Coggon; C Cooper
Journal:  Rheumatology (Oxford)       Date:  2002-09       Impact factor: 7.580

6.  Labor force participation among persons with musculoskeletal conditions, 1970-1987. National estimates derived from a series of cross-sections.

Authors:  E H Yelin; P P Katz
Journal:  Arthritis Rheum       Date:  1991-11

7.  Patient satisfaction and function after primary and revision total hip replacement.

Authors:  B Espehaug; L I Havelin; L B Engesaeter; N Langeland; S E Vollset
Journal:  Clin Orthop Relat Res       Date:  1998-06       Impact factor: 4.176

  7 in total
  13 in total

1.  Socio-economic impact of Birmingham hip resurfacing on patient employment after ten years.

Authors:  Ibrahim A Malek; Munawar Hashmi; James P Holland
Journal:  Int Orthop       Date:  2010-11-27       Impact factor: 3.075

Review 2.  The older worker with osteoarthritis of the knee.

Authors:  Keith T Palmer
Journal:  Br Med Bull       Date:  2012-04-26       Impact factor: 4.291

3.  Understanding the Needs and Priorities of People Living with Persistent Pain and Long-Term Musculoskeletal Conditions during the COVID-19 Pandemic-A Public Involvement Project.

Authors:  Sally Fowler Davis; Helen Humphreys; Tom Maden-Wilkinson; Sarah Withers; Anna Lowe; Robert J Copeland
Journal:  Healthcare (Basel)       Date:  2022-06-17

4.  The effect of disease site (knee, hip, hand, foot, lower back or neck) on employment reduction due to osteoarthritis.

Authors:  Eric C Sayre; Linda C Li; Jacek A Kopec; John M Esdaile; Sherry Bar; Jolanda Cibere
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

5.  Employment status and personal characteristics in patients awaiting hip-replacement surgery.

Authors:  Eric R Bohm
Journal:  Can J Surg       Date:  2009-04       Impact factor: 2.089

6.  The effect of total knee replacement on employment in patients under 60 years of age.

Authors:  H Lyall; John Ireland; M Y El-Zebdeh
Journal:  Ann R Coll Surg Engl       Date:  2009-04-02       Impact factor: 1.891

7.  Understanding the patient-reported factors determining time taken to return to work after hip and knee arthroplasty.

Authors:  B D Kleim; A Malviya; S Rushton; M Bardgett; D J Deehan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-06       Impact factor: 4.342

8.  Health-related job loss: findings from a community-based survey.

Authors:  Christine Solomon; Jason Poole; Keith T Palmer; David Coggon
Journal:  Occup Environ Med       Date:  2006-11-09       Impact factor: 4.402

Review 9.  HIP osteoarthritis and work.

Authors:  E Clare Harris; David Coggon
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-06-10       Impact factor: 4.098

Review 10.  Ageing, musculoskeletal health and work.

Authors:  Keith T Palmer; Nicola Goodson
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-04-15       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.